Showing results (1341-1350 of 1,391) with videos related to

Sort By:
Pageof 140
Environmental Toxicology and Chemistry|August 27, 2024
Chronic Toxicity of Per- and Polyfluoroalkyl Substance-Free Firefighting Foams to Aquatic OrganismsNeil Fuller, Jamie G Suski, Sarah Lanasa, et al.
Cellular and Molecular Life Sciences : CMLS|January 21, 2009
A sperm GPI-anchored protein elicits sperm-cumulus cross-talk leading to the acrosome reactionL Yin, C M Chung, R Huo, et al.
Frontiers in Immunology|August 15, 2022
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Oncogene|July 17, 2012
CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancerC Xie, X H Jiang, J T Zhang, et al.
Iscience|October 10, 2022
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2Phillip Pymm, Samuel J Redmond, Olan Dolezal, et al.
Frontiers in Immunology|January 27, 2023
Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2Bruce D Wines, Liriye Kurtovic, Halina M Trist, et al.
Clinical & Translational Immunology|March 8, 2021
Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody featuresLouise C Rowntree, Brendon Y Chua, Suellen Nicholson, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Unfolded Von Willebrand Factor Binds Protein S and Reduces Anticoagulant ActivityMartha M S Sim, Molly Y Mollica, Hammodah R Alfar, et al.
Blood Vessels, Thrombosis & Hemostasis|June 16, 2025
Unfolded von Willebrand factor binds protein S and reduces anticoagulant activityMartha M S Sim, Molly Y Mollica, Hammodah R Alfar, et al.
Nature Communications|March 14, 2023
Reference compounds for characterizing cellular injury in high-content cellular morphology assaysJayme L Dahlin, Bruce K Hua, Beth E Zucconi, et al.
Pageof 140